Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada flag Canada · Delayed Price · Currency is CAD
16.92
-0.06 (-0.35%)
May 20, 2026, 4:00 PM EST

Cipher Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6.417.4917.8439.8328.8420.55
Cash & Short-Term Investments
6.417.4917.8439.8328.8420.55
Cash Growth
-70.86%-57.99%-55.21%38.11%40.34%124.76%
Accounts Receivable
9.7511.2113.865.096.86.66
Inventory
8.28.195.792.982.151.65
Other Current Assets
1.141.1610.380.370.47
Total Current Assets
25.528.0538.4848.2738.1629.33
Net Property, Plant & Equipment
0.480.570.680.40.480.5
Other Intangible Assets
70.8572.0178.751.762.753.65
Goodwill
17.4517.4517.4515.7115.7115.71
Other Long-Term Assets
39.0138.4327.1519.8916.672.47
Total Assets
153.28156.5162.5186.0373.7851.65
Accounts Payable
6.56.395.874.64.115.56
Current Portion of Leases
0.260.290.280.090.10.06
Unearned Revenue
13.618.3513.310.560.260.45
Other Current Liabilities
0.010.010.41-4.96.23
Total Current Liabilities
20.3725.0419.875.259.3712.29
Long-Term Debt
-540---
Long-Term Leases
0.170.220.30.260.330.46
Total Long-Term Liabilities
0.175.2240.30.260.330.46
Total Liabilities
20.5330.2660.175.519.712.75
Common Stock
28.127.8627.6818.0117.7218.12
Additional Paid-in Capital
7.897.796.535.765.365.09
Accumulated Other Comprehensive Income
-9.51-9.51-9.51-9.51-9.51-9.51
Retained Earnings
106.28100.1177.6566.2750.5225.2
Shareholders' Equity
132.75126.24102.3480.5264.0838.9
Total Liabilities & Equity
153.28156.5162.5186.0373.7851.65
Total Debt
0.435.5140.580.350.430.52
Net Cash (Debt)
5.981.99-22.7439.4728.4120.03
Net Cash Growth
200.90%--38.95%41.81%174.67%
Net Cash Per Share
0.230.08-0.901.551.060.75
Book Value
132.75126.24102.3480.5264.0838.9
Book Value Per Share
5.064.874.063.172.391.45
Tangible Book Value
44.4536.786.1463.0545.6219.54
Tangible Book Value Per Share
1.701.420.242.481.700.73
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.